Reviva Pharmaceuticals Holdings, Inc. (RVPH) Dividend History

Reviva Pharmaceuticals Holdings, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. Founded to leverage its expertise in drug discovery and development, Reviva aims to address unmet medical needs through innovative solutions. The company's pipeline includes candidates targeting conditions such as depression, anxiety, and other neuropsychiatric disorders.

10080 N Wolfe Road, Cupertino, CA, 95014
Phone: (408) 501-8881
Website: https://www.revivapharma.com

Dividend History

Reviva Pharmaceuticals Holdings, Inc. currently does not pay dividends

Company News

  • Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight

    The schizophrenia market is expected to grow significantly by 2034, driven by rising disease prevalence, expanding approved therapies, and the anticipated launch of new treatments such as Olanzapine LAI, Iclepertin, Ulotaront, and Brilaroxazine.

    GlobeNewswire Inc.
    Featured Companies: NERV
  • Analyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stock

    Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are surging after the company released topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine signaling modulator in adults with schizophrenia.  The trial met its primary endpoint, with brilaroxazine at the 50 mg dose achieving a statistically significant and clinically meaningful 10.1-point reduction in Positive and Negative Syndrome Scale (PANSS) total score compared to placebo (-23.9 brilaroxazine 50 mg vs. -13.8 placebo) at week 4.  Roth Capital Partners writes that the data is robust across multiple endpoints, including ...Full story available on Benzinga.com

    Benzinga
  • 4 Penny Stocks To Buy According To Analysts Right Now

    Penny stocks with bullish analyst ratings. Time to buy or avoid entirely? The post 4 Penny Stocks To Buy According To Analysts Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: AMBP EGHT
Page data last updated 07/23/2025 10:09:10 UTC